Publications by authors named "Maoxin Ran"

Claim this Profile
I
Identifying meaningful drug response biomarkers from public pharmacogenomic datasets with biologically informed interpretable neural networks.
Maoxin Ran, Shao-Lin Zhang, Kin Yip Tam

Comput Biol Chem· February 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An orally administered quinolinium molecule mitigates neuropathology of Alzheimer's disease through modulation of mitochondrial dysfunction and neuroinflammation.
Junqiu He, Maoxin Ran, Kin Yip Tam

Brain Res· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suppressing protein damage response to overcome multidrug resistance in cancer therapy.
Fangyuan Shao, Zongjie Li, Hao Xiao, Yujun Chen, Yuheng Zhang, Maoxin Ran

Cell Discov· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Metabolic Vulnerabilities Reveals Hexokinase 2 as a Key Mediator of Resistance to Osimertinib in Non-Small Cell Lung Cancer Models.
Yizhen Guo, Ding Huang, Yan Zhou, Maoxin Ran, Shaolin Zhang

ACS Pharmacol Transl Sci· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting hexokinase 2 to enhance anticancer efficacy of trichosanthin in HeLa and SCC25 cell models.
Yan Zhou, Maoxin Ran, Wenying Shan, Kaifang Wang, Ou Sha

ADMET DMPK· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring casual effects and shared molecular mechanism between psoriasis and liver cancer through Mendelian randomization and comprehensive bioinformatic analyses.
Maoxin Ran, Ou Sha, Kin Yip Tam

Comput Biol Chem· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigallocatechin gallate circumvents drug-induced resistance in non-small-cell lung cancer by modulating glucose metabolism and AMPK/AKT/MAPK axis.
Yan Zhou, Shiqi Huang, Yizhen Guo, Maoxin Ran, Wenying Shan

Phytother Res· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined inhibition of pyruvate dehydrogenase kinase 1 and lactate dehydrogenase a induces metabolic and signaling reprogramming and enhances lung adenocarcinoma cell killing.
Yan Zhou, Yizhen Guo, Maoxin Ran, Wenying Shan, Carlotta Granchi

Cancer Lett· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytosolic malic enzyme and glucose-6-phosphate dehydrogenase modulate redox balance in NSCLC with acquired drug resistance.
Maoxin Ran, Yan Zhou, Yizhen Guo, Ding Huang, Shao-Lin Zhang

FEBS J· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A review of invasive intracranial pressure monitoring following surgery for hypertensive cerebral hemorrhage.
Fu Chen, Shukui Zhang, Bingzhen Li, Jin Zhang, Maoxin Ran

Front Neurol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dichloroacetophenone biphenylsulfone ethers as anticancer pyruvate dehydrogenase kinase inhibitors in non-small cell lung cancer models.
Yizhen Guo, Yan Zhou, Puhua Wu, Maoxin Ran, Ngai Xu

Chem Biol Interact· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis